Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study-Reference-Cited by-同舟云学术

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

Published:2010-01-27 Issue:6 Volume:51 Page:2069-2076
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bruno Savino,Crosignani Andrea,Facciotto Corinna,Rossi Sonia,Roffi Luigi,Redaelli Alessandro,de Franchis Roberto,Almasio Piero Luigi,Maisonneuve Patrick

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;Fattovich;Gastroenterology,1997

2. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death;Degos;Gut,2000

3. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications;Benvegnù;Gut,2004

4. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients;Sangiovanni;Hepatology,2006

5. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study;Bruno;Am J Gastroenterol,2009

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan;Digestive Diseases and Sciences;2024-07-04

2. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan;2024-04-10

3. Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals;Journal of Clinical Medicine;2023-03-12

4. Hepatitis C Virus prediction based on machine learning framework: a real-world case study in Egypt;Knowledge and Information Systems;2023-03-02

5. Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis;Viruses;2023-01-16